This information is part of the archives and is no longer current and may no longer be accurate.

Receive E-mail Alerts

Date Title   05/03/12 DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology 05/03/12 DURECT Corporation Announces First Quarter 2012 Financial Results and Update of Programs 04/25/12 DURECT Corporation Invites You to Join its First Quarter 2012 Earnings Conference Call 03/29/12 DURECT Receives Back U.S. and Canadian Product Rights to POSIDUR™ 03/01/12 DURECT Corporation Announces Fourth Quarter and Year End 2011 Financial Results 02/24/12 DURECT Corporation Invites You to Join Its Fourth Quarter 2011 Earnings Conference Call 02/23/12 DURECT to Participate in Upcoming Healthcare Conferences 02/07/12 DURECT to Present at the BIO CEO & Investor Conference 01/30/12 DURECT Receives Back European Product Rights to POSIDUR™ 01/05/12 DURECT Announces Top-line Data from BESST (POSIDUR® U.S. Pivotal Phase III Trial)